Platelet transfusion: A review of key concepts

Immunohematology

Volumn 12, Issue 3, 1996, Pages 123-126

  Sheinbaum, A J ^a   Herman, J H ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; BLOOD DONOR; BONE MARROW TRANSPLANTATION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 0029786332     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hersh EM, Bodey GP, Nies BA, Freireich EJ. Cause of death in acute leukemia: a ten year study on 414 patients from 1954-1963. JAMA 1965;193:99-103.
2. Han T, Stutzman L, Cohen E, Kim V. Effect of platelet transfusion on hemorrhage in patients with acute leukemia. An autopsy study. Cancer 1966;19:1937-42.
3. Freireich EJ, Kilman A, Gaydos LA, et al. Response to repeated platelet transfusion from the same donor. Ann Int Med 1963;59:277-87.
4. Lee EJ. Indications for platelet transfusion therapy. In: Clinical decisions in platelet therapy. Kurtz SA, Brubaker DB, eds. Bethesda, MD: American Association of Blood Banks, 1992:19-30.
5. Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 1962;266:905-9.
6. Belt RJ, Leite C, Haas CD, Stephens RL. Incidence of hemorrhagic complications in patients with cancer. JAMA 1978;239:2571-4.
7. Dutcher JP, Schiffer CA, Aisner J, et al. Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumor. Cancer 1984;67:13-22.
8. Beutler E. Platelet transfusions: the 20,000 μL trigger. Blood 1993;81:1411-3.
9. Slichter SJ, Harker LA. Thrombocytopenia: mechanisms and management of defects in platelet production. Clin Hematol 1978;7:523-40.
10. Alvarado J, Djerassi I, Farber S. Transfusion of fresh, concentrated platelets to children with acute leukemia. J Ped 1965;67:13-22.
11. Djerassi I, Farber S, Evans AE. Transfusion of fresh platelet concentrates to patients with secondary thrombocytopenia. N Engl J Med 1963;268:221-6.
12. Pisciotto PT, Benson K, Hume H, et al. Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients. Transfusion 1995;35:498-502.
13. Gmur J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia. Lancet 1991;338:1223-6.
14. Strauss RA. Clinical perspectives of platelet transfusions: defining the optimal dose. J Clinical Apheresis 1995;10:124-7.
15. Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985;56:1105-9.
16. Norol F, Duedari N, Kuentz M, et al. Comparison of different doses of platelet transfusion (abstract). Blood 1995;86 (suppl):353a.
17. Herman JH, Klumpp TR, Christman RA, et al. The effect of platelet dose on the outcome of prophylactic platelet transfusion (abstract). Transfusion 1995;35(suppl):46S.
18. Daly PA, Schiffer CA, Aisner J, Wiemik P. Platelet transfusion therapy: 1-hour post-transfusion increments are valuable in predicting the need for HLA initial preparation. JAMA 1980;243:435-8.
19. Hogge DE, Dutcher JP, Aisner JP, et al. Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion. Am J Hematol 1983;14:363-9.
20. Kickler TS, Braine HG, Ness PM. The predictive value of cross-matching platelet transfusion for alloimmunized patients. Transfusion 1985;25:385-90.